Treatment results of patients with complicated parapneumonic effusion and empyema

C. Demir, S. Atilla, A. Özcan, S. Özkara (Kecioren, Turkey)

Source: Annual Congress 2002 - Pneumonias: aetiology; management; antimicrobial resistance; empyema
Session: "Pneumonias: aetiology; management; antimicrobial resistance; empyema"
Session type: Thematic Poster Session
Number: 2216
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Demir, S. Atilla, A. Özcan, S. Özkara (Kecioren, Turkey). Treatment results of patients with complicated parapneumonic effusion and empyema. Eur Respir J 2002; 20: Suppl. 38, 2216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Management of parapneumonic effusion and empyema in children
Source: Eur Respir J 2002; 20: Suppl. 38, 589s
Year: 2002

Late period pulmonary functions of the patients who were treated for parapneumonic effusion and empyema
Source: Eur Respir J 2006; 28: Suppl. 50, 488s
Year: 2006

Parapneumonic effusion and empyema
Source: Respipedia Article
Year: 2017

Lung function in children post parapneumonic effusion and empyema
Source: Eur Respir J 2002; 20: Suppl. 38, 590s
Year: 2002

Treatment of parapneumonic pleural effusion and empyema: conservative view
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=199
Year: 2004

Predictors of outcome in parapneumonic pleural effusions in children
Source: Eur Respir J 2001; 18: Suppl. 33, 171s
Year: 2001

Efficacy of intrapleural streptokinase use in complicated parapneumonic pleural effusions and empyema
Source: Annual Congress 2008 - Pleural effusion
Year: 2008


Predictive factors, microbiology and outcome of patients with parapneumonic effusion
Source: Eur Respir J 2011; 38: 1173-1179
Year: 2011



Update on the management of parapneumonic pleural effusions
Source: Virtual Congress 2021 – Spanish/Portuguese programme 2021
Year: 2021


Empyema and parapneumonic pleural effusion. Prognostic factors about 109 patients
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009


Role of pulmonary scintigraphy in children post parapneumonic effusion and empyema
Source: Eur Respir J 2001; 18: Suppl. 33, 170s
Year: 2001

Role of C-reactive protein in discriminating complicated and uncomplicated parapneumonic effusion from malignant and tuberculous pleural effusion
Source: Virtual Congress 2021 – Clinical problems associated with cough, pleura and respiratory health status
Year: 2021


Parapneumonic pleural effusion as a cause of hypoalbumunemia in pediatric patients
Source: Eur Respir J 2006; 28: Suppl. 50, 309s
Year: 2006

Treatment of children with pleural effusion
Source: Eur Respir J 2007; 30: Suppl. 51, 243s
Year: 2007

Intrapleural tenectaplase therapy in treatment of loculated parapneumonic pleural effusions and empyema
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015

Thoracoscopy to management of parapneumonic effusion (PPE) in pediatric patients
Source: Eur Respir J 2002; 20: Suppl. 38, 538s
Year: 2002

Risk factors for parapneumonic effusion in community-asquired pneumonia
Source: International Congress 2019 – Pleural infection and complicated pneumonia
Year: 2019